Influenza vaccineCOPDWe evaluated the immunogenicity of a reduced-dose intradermal trivalent, inactivated, split-virion seasonal influenza vaccine compared to that of a conventional intramuscular vaccination in chronic obstructive pulmonary disease (COPD) patients. One hundred and fifty-six COPD patients ...
Chronic Obstructive Pulmonary Disease: A guide for the primary care physician Influenza vaccine Theinfluenza vaccineshould be given to allCOPDpatients annually. Influenza vaccine reduces the incidence of influenza and thereforeCOPD exacerbationcaused by the virus.96The vaccination itself, does not cause ex...
Influenza vaccination and in particular the use of the seasonal trivalent influenza vaccine (TIV) is recommended for patients with COPD. The evidence base for its effects in this population is, however, limited. Available data suggest that immunogenicity is variable in COPD but the underlying ...
Despite clear recommendations from national and international health authorities, vaccine coverage rates among eligible patients in many countries remain below 50%. There are several reasons for this, top among which are misinformation and misperceptions of the personal risk or the potential serious ...
High-dose influenza vaccine (egg-based) 65 years Off-label for individuals aged 18–64 years who have received a solid organ transplant and are on immunosuppressants Live-attenuated influenza vaccine (egg-based) 2 years Intranasal spray Recombinant influenza vaccine (synthetically created without...
COPD-related morbidity and mortality.[17,18]In a small randomized trial[8]with 55 subjects, influenza vaccination significantly reduced the rate of COPD exacerbations; while in another randomized, double-blinded, placebo-controlled trial[13]with 125 patients, the vaccine reduced influenza-related ...
Inactivated Split-Virion Seasonal Influenza Vaccine (FluarixÒ) A Review of its Use in the Prevention of Seasonal Influenza in Adults and the Elderly Monique P. Curran1 and Isabel Leroux-Roels2 1 Adis, a Wolters Kluwer Business, Auckland, New Zealand 2 Centre for Vaccinology, Ghent University...
Despite the benefits of influenza vaccination, there continues to be low vaccine coverage among adults admitted to the ICU who often have a high prevalence of high-risk comorbidities [45,46]. In children, low influenza vaccination coverage has also been reported among those admitted to pediatric ...
To work on these improvements, targeting individuals with barriers to receive the vaccine and using the role of nephrology care to promote vaccination could be beneficial.1 “Importantly, nephrology care may represent an important opportunity to increase vaccine uptake in patients with CKD by ...
hospital stay at the extremes of age was 5 days for infants and 8 days for the elderly, highlighting the fact that these age groups are disproportionately affected by influenza and drawing attention to the burden on the healthcare system and the patient, caused by a vaccine-preventable disease...